We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Enabling Technology in Cell-Based Therapies: Scale-Up, Scale-Out or Program In-Place

News   Jul 23, 2018 | Original story from SLAS

 
Enabling Technology in Cell-Based Therapies: Scale-Up, Scale-Out or Program In-Place

Technologies that are reducing costs and changing the ways in which researchers and clinicians process and use therapeutic cells are showcased in the August 2018 special issue of SLAS Technology. Credit: Coleman Murray, University of California, Los Angeles

 
 
 

RELATED ARTICLES

Is There a Link Between Herpes and Alzheimer's?

News

Possible links between herpes and Alzheimer's disease have been assessed in a recent review.

READ MORE

Immune Therapy Shows Promise for Ankylosing Spondylitis

News

Patients who have not benefited from standard therapy for ankylosing spondylitis (AS), a chronic inflammatory disease characterized by back pain and sacroiliac-joint damage, may soon have another option.

READ MORE

Making Custom-designed Natural Products

News

Microorganisms often assemble natural products similar to industrial assembly lines. Certain enzymes, non-ribosomal peptide synthetases (NRPS) play a key role in this process. Biotechnologists have now discovered how these enzymes interact with each other, bringing them one step closer to their goal of engineering peptide natural products.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE